Fix NHS drugs rebate or UK investment at risk, Big Pharma warns
AstraZeneca, GSK and other multinationals urge the government to make its branded medicines scheme ‘internationally competitive’ as part of its growth strategy
Continue reading this article about Fix NHS drugs rebate or UK investment at risk, Big Pharma warns
by Alex Ralph, Chief Business Correspondent
NHS Forums - For daily discussion by NHS Staff.

AstraZeneca, GSK and other multinationals urge the government to make its branded medicines scheme ‘internationally competitive’ as part of its growth strategy
Continue reading this article about Fix NHS drugs rebate or UK investment at risk, Big Pharma warns
by Alex Ralph, Chief Business Correspondent
NHS Forums - For daily discussion by NHS Staff.